Literature DB >> 9199241

A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor.

O Valdenaire1, T Giller, V Breu, J Gottowik, G Kilpatrick.   

Abstract

We have identified the human counterpart of the corticotropin-releasing factor receptor subtype 2beta. Its functional response to human urocortin was demonstrated after stable expression in HEK-293 cells. The receptor was also shown to bind sauvagine, corticotropin-releasing factor and urocortin. In contrast to rodents, the human CRF(2beta) receptor is only weakly expressed in heart and skeletal tissues, where the CRF(2alpha) isoform is predominant. Moreover, we have identified additional mRNAs of the CRF(2beta) type which are probably a consequence of aberrant splicing events.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199241     DOI: 10.1016/s0167-4781(97)00047-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

Review 1.  Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family.

Authors:  Pasquale Florio; Filiberto M Severi; Pasquapina Ciarmela; Giovina Fiore; Giulia Calonaci; Angelica Merola; Claudio De Felice; Marco Palumbo; Felice Petraglia
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.

Authors:  A Rühmann; I Bonk; C R Lin; M G Rosenfeld; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 3.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

Review 4.  Corticotropin-releasing factor signaling and visceral response to stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Exp Biol Med (Maywood)       Date:  2010-10

Review 5.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

Review 6.  The CRF system, stress, depression and anxiety-insights from human genetic studies.

Authors:  E B Binder; C B Nemeroff
Journal:  Mol Psychiatry       Date:  2009-12-15       Impact factor: 15.992

7.  CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.

Authors:  Katherine E Wiley; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

Review 8.  Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

Authors:  H Lehnert; C Schulz; K Dieterich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

9.  Differential expression of a cutaneous corticotropin-releasing hormone system.

Authors:  Andrzej Slominski; Alexander Pisarchik; Desmond J Tobin; Joseph E Mazurkiewicz; Jacobo Wortsman
Journal:  Endocrinology       Date:  2003-11-06       Impact factor: 4.736

10.  Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha.

Authors:  Alan C Moss; Pauline Anton; Tor Savidge; Paul Newman; Adam S Cheifetz; Jerome Gay; Sophia Paraschos; Michael Weinstein Winter; Mary P Moyer; Katia Karalis; Efi Kokkotou; Charalabos Pothoulakis
Journal:  Gut       Date:  2007-04-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.